Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Gene Expression Classifier Testing and the Surgical Decision-Making Process for Patients With Thyroid Nodules—Reply
1
Zitationen
3
Autoren
2016
Jahr
Abstract
In Reply Drs Kloos and Barth,1 employees and equity owners of Veracyte raise questions about the design and findings of our study examining the effect of Veracyte's Afirma gene expression classifier (GEC) on the practice of 10 thyroid surgeons at an academic institution.2
Ähnliche Arbeiten
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 · 16.124 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.725 Zit.
Serum TSH, T<sub>4</sub>, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 · 3.836 Zit.
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
2006 · 3.353 Zit.
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2014 · 3.018 Zit.